N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide

C135H110ClN29O9S — CID 159288619

IUPACN-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(C)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(CO)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(Cl)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]ccc3n2)c1
InChIInChI=1S/C26H27N5O3S.C24H19N5O2.C24H19N5O.C23H16ClN5O.C23H17N5O.C15H12N4O/c1-6-23(32)29-19-11-7-10-18(13-19)22-16-28-25-24(30-22)21(15-27-25)17-9-8-12-20(14-17)35(33,34)31(5)26(2,3)4;1-2-22(31)27-17-5-3-4-15(9-17)21-12-26-24-23(29-21)18(11-25-24)20-10-16-7-6-14(13-30)8-19(16)28-20;1-3-22(30)27-17-6-4-5-15(10-17)21-13-26-24-23(29-21)18(12-25-24)20-11-16-8-7-14(2)9-19(16)28-20;1-2-21(30)27-16-5-3-4-13(8-16)20-12-26-23-22(29-20)17(11-25-23)19-9-14-6-7-15(24)10-18(14)28-19;1-2-21(29)26-16-8-5-7-14(10-16)20-13-25-23-22(28-20)17(12-24-23)19-11-15-6-3-4-9-18(15)27-19;1-2-14(20)18-11-5-3-4-10(8-11)13-9-17-15-12(19-13)6-7-16-15/h6-16H,1H2,2-5H3,(H,27,28)(H,29,32);2-12,28,30H,1,13H2,(H,25,26)(H,27,31);3-13,28H,1H2,2H3,(H,25,26)(H,27,30);2-12,28H,1H2,(H,25,26)(H,27,30);2-13,27H,1H2,(H,24,25)(H,26,29);2-9H,1H2,(H,16,17)(H,18,20)
InChIKeyKZVCIMWPMLDNJN-UHFFFAOYSA-N
MW2350.08 g/mol
LogP27.63
Rot. Bonds26

About N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide

N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide (PubChem CID 159288619) has the molecular formula C135H110ClN29O9S and a molecular weight of 2350.08 g/mol. Its IUPAC name is N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide.

Molecular Properties

Compound NameN-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide
PubChem CID159288619
Molecular FormulaC135H110ClN29O9S
Molecular Weight2350.08 g/mol
Exact Mass2347.85
IUPAC NameN-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(C)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(CO)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(Cl)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]ccc3n2)c1
InChIInChI=1S/C26H27N5O3S.C24H19N5O2.C24H19N5O.C23H16ClN5O.C23H17N5O.C15H12N4O/c1-6-23(32)29-19-11-7-10-18(13-19)22-16-28-25-24(30-22)21(15-27-25)17-9-8-12-20(14-17)35(33,34)31(5)26(2,3)4;1-2-22(31)27-17-5-3-4-15(9-17)21-12-26-24-23(29-21)18(11-25-24)20-10-16-7-6-14(13-30)8-19(16)28-20;1-3-22(30)27-17-6-4-5-15(10-17)21-13-26-24-23(29-21)18(12-25-24)20-11-16-8-7-14(2)9-19(16)28-20;1-2-21(30)27-16-5-3-4-13(8-16)20-12-26-23-22(29-20)17(11-25-23)19-9-14-6-7-15(24)10-18(14)28-19;1-2-21(29)26-16-8-5-7-14(10-16)20-13-25-23-22(28-20)17(12-24-23)19-11-15-6-3-4-9-18(15)27-19;1-2-14(20)18-11-5-3-4-10(8-11)13-9-17-15-12(19-13)6-7-16-15/h6-16H,1H2,2-5H3,(H,27,28)(H,29,32);2-12,28,30H,1,13H2,(H,25,26)(H,27,31);3-13,28H,1H2,2H3,(H,25,26)(H,27,30);2-12,28H,1H2,(H,25,26)(H,27,30);2-13,27H,1H2,(H,24,25)(H,26,29);2-9H,1H2,(H,16,17)(H,18,20)
InChIKeyKZVCIMWPMLDNJN-UHFFFAOYSA-N
XLogP27.63
TPSA544.79 Ų
H-Bond Donors17
H-Bond Acceptors21
Rotatable Bonds26
Heavy Atoms175
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002350.08
LogP ≤ 527.63
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide?
The IUPAC name of N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide (CID 159288619) is N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide.
What is the SMILES notation for N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide?
The canonical SMILES for N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide is C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(C)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(CO)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccc(Cl)cc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cc5ccccc5[nH]4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]cc(-c4cccc(S(=O)(=O)N(C)C(C)(C)C)c4)c3n2)c1.C=CC(=O)Nc1cccc(-c2cnc3[nH]ccc3n2)c1.
What is the InChIKey of N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide?
The InChIKey is KZVCIMWPMLDNJN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27N5O3S.C24H19N5O2.C24H19N5O.C23H16ClN5O.C23H17N5O.C15H12N4O/c1-6-23(32)29-19-11-7-10-18(13-19)22-16-28-25-24(30-22)21(15-27-25)17-9-8-12-20(14-17)35(33,34)31(5)26(2,3)4;1-2-22(31)27-17-5-3-4-15(9-17)21-12-26-24-23(29-21)18(11-25-24)20-10-16-7-6-14(13-30)8-19(16)28-20;1-3-22(30)27-17-6-4-5-15(10-17)21-13-26-24-23(29-21)18(12-25-24)20-11-16-8-7-14(2)9-19(16)28-20;1-2-21(30)27-16-5-3-4-13(8-16)20-12-26-23-22(29-20)17(11-25-23)19-9-14-6-7-15(24)10-18(14)28-19;1-2-21(29)26-16-8-5-7-14(10-16)20-13-25-23-22(28-20)17(12-24-23)19-11-15-6-3-4-9-18(15)27-19;1-2-14(20)18-11-5-3-4-10(8-11)13-9-17-15-12(19-13)6-7-16-15/h6-16H,1H2,2-5H3,(H,27,28)(H,29,32);2-12,28,30H,1,13H2,(H,25,26)(H,27,31);3-13,28H,1H2,2H3,(H,25,26)(H,27,30);2-12,28H,1H2,(H,25,26)(H,27,30);2-13,27H,1H2,(H,24,25)(H,26,29);2-9H,1H2,(H,16,17)(H,18,20).
What are the key properties of N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide?
N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide has a molecular weight of 2350.08 g/mol, XLogP of 27.63, 26 rotatable bonds, 17 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[7-[3-[tert-butyl(methyl)sulfamoyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-chloro-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-[6-(hydroxymethyl)-1H-indol-2-yl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-[7-(6-methyl-1H-indol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]phenyl]prop-2-enamide;N-[3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)phenyl]prop-2-enamide is sourced from PubChem (CID 159288619), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).